Cargando…
KIF22 promotes bladder cancer progression by activating the expression of CDCA3
Bladder cancer is a common malignant tumor of the urinary system and is associated with a high morbidity and mortality, due to the difficulty in the accurate diagnosis of patients with early-stage bladder cancer and the lack of effective treatments for patients with advanced bladder cancer. Thus, no...
Autores principales: | Li, Kai, Li, Song, Tang, Shuai, Zhang, Minghao, Ma, Zhen, Wang, Qi, Chen, Fangmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522959/ https://www.ncbi.nlm.nih.gov/pubmed/34633053 http://dx.doi.org/10.3892/ijmm.2021.5044 |
Ejemplares similares
-
[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023) -
KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2021) -
KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2023) -
CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018) -
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)